209 related articles for article (PubMed ID: 35455366)
1. Efficacy and Effectiveness of the Meningococcal Conjugate Group A Vaccine MenAfriVac
Viviani S
Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455366
[TBL] [Abstract][Full Text] [Related]
2. Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps.
LaForce FM; Djingarey M; Viviani S; Preziosi MP
Hum Vaccin Immunother; 2018 May; 14(5):1098-1102. PubMed ID: 28968148
[TBL] [Abstract][Full Text] [Related]
3. Serogroup A meningococcal conjugate vaccines in Africa.
Kristiansen PA; Jørgensen HJ; Caugant DA
Expert Rev Vaccines; 2015; 14(11):1441-58. PubMed ID: 26358167
[TBL] [Abstract][Full Text] [Related]
4. Status of the Rollout of the Meningococcal Serogroup A Conjugate Vaccine in African Meningitis Belt Countries in 2018.
Bwaka A; Bita A; Lingani C; Fernandez K; Durupt A; Mwenda JM; Mihigo R; Djingarey MH; Ronveaux O; Preziosi MP
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S140-S147. PubMed ID: 31671448
[TBL] [Abstract][Full Text] [Related]
5. Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.
Novak RT; Kambou JL; Diomandé FV; Tarbangdo TF; Ouédraogo-Traoré R; Sangaré L; Lingani C; Martin SW; Hatcher C; Mayer LW; Laforce FM; Avokey F; Djingarey MH; Messonnier NE; Tiendrébéogo SR; Clark TA
Lancet Infect Dis; 2012 Oct; 12(10):757-64. PubMed ID: 22818241
[TBL] [Abstract][Full Text] [Related]
6. Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.
Mohammed I; Iliyasu G; Habib AG
Pathog Glob Health; 2017 Feb; 111(1):1-6. PubMed ID: 28081671
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of meningitis surveillance before introduction of serogroup a meningococcal conjugate vaccine - Burkina Faso and Mali.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(50):1025-8. PubMed ID: 23254257
[TBL] [Abstract][Full Text] [Related]
8. Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac®.
Trotter CL; Cibrelus L; Fernandez K; Lingani C; Ronveaux O; Stuart JM
Vaccine; 2015 Nov; 33(46):6212-7. PubMed ID: 26463444
[TBL] [Abstract][Full Text] [Related]
9. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
Xie O; Pollard AJ; Mueller JE; Norheim G
Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866
[TBL] [Abstract][Full Text] [Related]
10. Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization.
Meyer SA; Kambou JL; Cohn A; Goodson JL; Flannery B; Medah I; Messonnier N; Novak R; Diomande F; Djingarey MH; Clark TA; Yameogo I; Fall A; Wannemuehler K
Vaccine; 2015 Mar; 33(12):1492-8. PubMed ID: 25636915
[TBL] [Abstract][Full Text] [Related]
11. Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign.
Diallo AO; Soeters HM; Yameogo I; Sawadogo G; Aké F; Lingani C; Wang X; Bita A; Fall A; Sangaré L; Ouédraogo-Traoré R; Medah I; Bicaba B; Novak RT;
PLoS One; 2017; 12(11):e0187466. PubMed ID: 29095907
[TBL] [Abstract][Full Text] [Related]
12. The Establishment and Diversification of Epidemic-Associated Serogroup W Meningococcus in the African Meningitis Belt, 1994 to 2012.
Retchless AC; Hu F; Ouédraogo AS; Diarra S; Knipe K; Sheth M; Rowe LA; Sangaré L; Ky Ba A; Ouangraoua S; Batra D; Novak RT; Ouédraogo Traoré R; Wang X
mSphere; 2016; 1(6):. PubMed ID: 27904879
[TBL] [Abstract][Full Text] [Related]
13. Serogroup A meningococcal conjugate vaccine coverage after the first national mass immunization campaign-Burkina Faso, 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(50):1022-4. PubMed ID: 23254256
[TBL] [Abstract][Full Text] [Related]
14. [Meningococcal meningitis epidemics in sub-Saharan Africa and the meningococcal A conjugate vaccine].
Nicolas P
Med Sante Trop; 2012; 22(3):246-58. PubMed ID: 23186941
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine.
Caugant DA; Kristiansen PA; Wang X; Mayer LW; Taha MK; Ouédraogo R; Kandolo D; Bougoudogo F; Sow S; Bonte L
PLoS One; 2012; 7(9):e46019. PubMed ID: 23029368
[TBL] [Abstract][Full Text] [Related]
16. Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.
; Altmann D; Aseffa A; Bash M; Basta N; Borrow R; Broome C; Caugant D; Clark T; Collard JM; Djingarey M; Goldblatt D; Greenwood B; Griffiths U; Hajjeh R; Hassan-King M; Hugonnet S; Kimball AM; LaForce M; MacLennan C; Maiden MC; Manigart O; Mayer L; Messonnier N; Moisi J; Moore K; Moto DD; Mueller J; Nascimento M; Obaro S; Ouedraogo R; Page AL; Perea W; Pluschke G; Preziosi MP; Sow S; Stephens D; Stuart J; Thomson M; Tiendrebeogo S; Trape JF; Vernet G
Vaccine; 2013 Mar; 31(11):1453-7. PubMed ID: 23273967
[TBL] [Abstract][Full Text] [Related]
17. Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012.
Cibrelus L; Medah I; Koussoubé D; Yélbeogo D; Fernandez K; Lingani C; Djingarey M; Hugonnet S
Emerg Infect Dis; 2015 Nov; 21(11):2063-6. PubMed ID: 26488128
[TBL] [Abstract][Full Text] [Related]
18. Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM).
Frasch CE; Preziosi MP; LaForce FM
Hum Vaccin Immunother; 2012 Jun; 8(6):715-24. PubMed ID: 22495119
[TBL] [Abstract][Full Text] [Related]
19. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].
Daugla DM; Gami JP; Gamougam K; Naibei N; Mbainadji L; Narbé M; Toralta J; Kodbesse B; Ngadoua C; Coldiron ME; Fermon F; Page AL; Djingarey MH; Hugonnet S; Harrison OB; Rebbetts LS; Tekletsion Y; Watkins ER; Hill D; Caugant DA; Chandramohan D; Hassan-King M; Manigart O; Nascimento M; Woukeu A; Trotter C; Stuart JM; Maiden M; Greenwood BM
Lancet; 2014 Jan; 383(9911):40-47. PubMed ID: 24035220
[TBL] [Abstract][Full Text] [Related]
20. Serogroup A meningococcal conjugate vaccines: building sustainable and equitable vaccine strategies.
Sherman AC; Stephens DS
Expert Rev Vaccines; 2020 May; 19(5):455-463. PubMed ID: 32321332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
